Epilepsy Clinical Trials

Showing 881-900 of 910 trials

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

NCT00236886

The purpose of this study is to assess a possible predictor for weight loss seen in epilepsy patients treated with topiramate.

EpilepsyEpilepsies, PartialEpilepsy, Generalized+1 more

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.49 participantsStarted May 1998

WITHDRAWNNA

Verapamil and Catamenial Epilepsy

NCT00559169

One in 3 epilepsy patients have refractory seizures. This drug resistance is likely related to the over expression of multidrug resistance proteins (MDR). Progesterone is a known inhibitor of MDRs and the low level of this hormone during the menstrual cycle may exacerbate seizures, perhaps explaining catamenial epilepsy; i.e. seizures occurring during the menstrual cycle. Verapamil suppresses seizures in animal models of epilepsy perhaps by inhibiting MDRs and thus may help patients with refractory seizures. If the study shows improved seizure control, the results will help establish the role of MDRs in refractory epilepsy.

Catamenial Epilepsy

University Health Network, Toronto12 participantsStarted Feb 2009

Toronto, Ontario, Canada

COMPLETEDPhase 1/2

Thalidomide Low Threshold in Epilepsy

NCT01061866

The purpose of this study is to determine whether thalidomide is effective in the refractory epilepsy treatment.

Refractory Epilepsy

National Institute of Neurology and Neurosurgery, Mexico7 participantsStarted Jun 2006

COMPLETEDPhase 4

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

NCT00154076

To assess the efficacy and safety of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Epilepsy

Eisai Korea Inc.140 participantsStarted Sep 2005

Daegu, South Korea

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Verapamil and Catamenial Epilepsy

Thalidomide Low Threshold in Epilepsy

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Related Searches

Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study

Affective Processing in Depression and Epilepsy

fMRI Investigation of Depression in Patients With Epilepsy

HEAD-Study Optimizing the Treatment of Children With BECTS

Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

Use of Sustained Release Antiepileptic Medication (Depakote® ER) for Pediatric Epilepsy in a Mental Retardation/Developmental Disorder Population

Lamotrigine and Oral Contraceptives

The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

Transcranial Magnetic Stimulation for the Treatment of Poorly Controlled Partial Epilepsy

Monitoring Patients With Uncontrolled Epilepsy

Functional Coupling of Cortico-Cortical and Cortico-Muscular Connections During Motor Movements: An Electrocorticographic Study of Ipsilateral Motor Control

Herpes Virus-6 and Epilepsy

Quality of Life and Adverse Effects in Epilepsy Patients (EPIKA)

The Influence of SISCOM on Intracranial Electrode Implantation in Epilepsy Surgical Candidates

Phase I Trail for Intramuscular Administration of Midazolam Using An Autoinjector